Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiqing Chen

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Rheumatology (Oxford, England)|July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trialDong Xu, Jianmin Fang, Shangzhu Zhang, et al.
Journal of Agricultural and Food Chemistry|December 21, 2023
Dual-Specificity Inhibitor Targets Enzymes of the Trehalose Biosynthesis PathwayYitong Chen, Liu Tang, Zhiyang Jiang, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Rheumatology (Oxford, England)|July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trialDong Xu, Jianmin Fang, Shangzhu Zhang, et al.
Journal of Agricultural and Food Chemistry|December 21, 2023
Dual-Specificity Inhibitor Targets Enzymes of the Trehalose Biosynthesis PathwayYitong Chen, Liu Tang, Zhiyang Jiang, et al.
Pageof 9